N-hydroxy-4-(2-(5'-nitro-2'-oxospiro[[1,3]dioxolane-2,3'-indoline]-1'-yl)acetamido)benzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-hydroxy-4-(2-(5'-nitro-2'-oxospiro[[1,3]dioxolane-2,3'-indoline]-1'-yl)acetamido)benzamide
• 英文别名: N-hydroxy-4-[[2-(5'-nitro-2'-oxospiro[1,3-dioxolane-2,3'-indole]-1'-yl)acetyl]amino]benzamide
• 化学式: C₁₉H₁₆N₄O₈
• 分子量: 428.358
• InChiKey: BHJWXCKOLFSPKI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  163
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  2-羟基亚氨基-N-(4-硝基苯基)-乙酰胺 在 N-甲基吗啉 、 盐酸 、 羟胺钾盐 、 硫酸 、 四丁基溴化铵 、 potassium carbonate 、 对甲苯磺酸 、 potassium iodide 、 potassium hydroxide 、 氯甲酸异丁酯 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 丙酮 、 甲苯 为溶剂， 反应 23.0h， 生成 N-hydroxy-4-(2-(5'-nitro-2'-oxospiro[[1,3]dioxolane-2,3'-indoline]-1'-yl)acetamido)benzamide
  参考文献：
  名称：

  Design, synthesis and preliminary biological evaluation of indoline-2,3-dione derivatives as novel HDAC inhibitors

  摘要：

  Histone deacetylases (HDACs) are zinc-dependent or NAD+ dependent enzymes and play a critical role in the process of tumor development. Herein a series of indoline-2,3-dione derivatives have been designed and synthesized as potential HDACs inhibitors. The preliminary biological evaluation showed that most compounds synthesized have exhibited moderate Hela cell nuclear extract inhibitory activities, among which compound 25a (IC50 = 10.13 nM) has shown the best efficacy. The anti-proliferative activities of some of these compounds were also discussed. (C) 2015 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2015.05.048

文献信息

• Design, synthesis and preliminary biological evaluation of indoline-2,3-dione derivatives as novel HDAC inhibitors
  作者：Kang Jin、Shanshan Li、Xiaoguang Li、Jian Zhang、Wenfang Xu、Xuechen Li

  DOI：10.1016/j.bmc.2015.05.048

  日期：2015.8

  Histone deacetylases (HDACs) are zinc-dependent or NAD+ dependent enzymes and play a critical role in the process of tumor development. Herein a series of indoline-2,3-dione derivatives have been designed and synthesized as potential HDACs inhibitors. The preliminary biological evaluation showed that most compounds synthesized have exhibited moderate Hela cell nuclear extract inhibitory activities, among which compound 25a (IC50 = 10.13 nM) has shown the best efficacy. The anti-proliferative activities of some of these compounds were also discussed. (C) 2015 Published by Elsevier Ltd.